Estimate of cross-border cigarette purchases in France 2004-2007

 

Estimate of cross-border cigarette purchases in France 2004-2007

Tendances n° 75, OFDT, 6 p.
March 2011

The volume and consequences of tobacco purchases that are not locally taxed, i.e., tobacco purchased by French people outside of the traditional French tobacconist network, have been the subject of lively debate. In France, several studies have already employed different methods to estimate the extent of tax evasion on tobacco products.

With a view to improving the robustness of the estimates, this issue of Tendances develops an approach which is based on a theoretical system that describes individual reasons for crossing borders, takes into consideration not only tobacco price differences between France and its border countries, but also the distance that separates individuals from the closest borders. The econometric analysis used here offers a way to quantify the influence of each determinant of cross-border tobacco purchases, all other things being equal. The analysis also finetunes the overall tax evasion estimates. For data availability reasons, and especially since cigarette demand has been greatly distorted due to anti-tobacco measures, the study period ran from 2004 to 2007. The estimated econometric model nevertheless provides an idea of the tobacco tax evasion trends for the most recent years.

At the same time, a survey on tobacco purchasing behaviours was conducted among smokers. This survey completes the analysis of the econometric model by highlighting the characteristics of users of foreign-purchased tobacco.

Authors :
Christian Ben Lakhdar, Aurélie Lermenier, Nicolas G. Vaillant

Download the PDF file (1 Mo)

Drugs in Europe


2017 EMCDDA European Drug Report

What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2017 EMCDDA European Drug Report.

Country drug reports

Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

The European Union and the drug phenomenon

The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.